JCI Insight (Jan 2023)

Spatial transcriptomic characterization of COVID-19 pneumonitis identifies immune circuits related to tissue injury

  • Amy R. Cross,
  • Carlos E. de Andrea,
  • María Villalba-Esparza,
  • Manuel F. Landecho,
  • Lucia Cerundolo,
  • Praveen Weeratunga,
  • Rachel E. Etherington,
  • Laura Denney,
  • Graham Ogg,
  • Ling-Pei Ho,
  • Ian S.D. Roberts,
  • Joanna Hester,
  • Paul Klenerman,
  • Ignacio Melero,
  • Stephen N. Sansom,
  • Fadi Issa

Journal volume & issue
Vol. 8, no. 2

Abstract

Read online

Severe lung damage resulting from COVID-19 involves complex interactions between diverse populations of immune and stromal cells. In this study, we used a spatial transcriptomics approach to delineate the cells, pathways, and genes present across the spectrum of histopathological damage in COVID-19–affected lung tissue. We applied correlation network–based approaches to deconvolve gene expression data from 46 areas of interest covering more than 62,000 cells within well-preserved lung samples from 3 patients. Despite substantial interpatient heterogeneity, we discovered evidence for a common immune-cell signaling circuit in areas of severe tissue that involves crosstalk between cytotoxic lymphocytes and pro-inflammatory macrophages. Expression of IFNG by cytotoxic lymphocytes was associated with induction of chemokines, including CXCL9, CXCL10, and CXCL11, which are known to promote the recruitment of CXCR3+ immune cells. The TNF superfamily members BAFF (TNFSF13B) and TRAIL (TNFSF10) were consistently upregulated in the areas with severe tissue damage. We used published spatial and single-cell SARS-CoV-2 data sets to validate our findings in the lung tissue from additional cohorts of patients with COVID-19. The resulting model of severe COVID-19 immune-mediated tissue pathology may inform future therapeutic strategies.

Keywords